Environmental concentrations of anti-androgenic pharmaceuticals do not impact sexual disruption in fish alone or in combination with steroid oestrogens by Green, Christopher et al.
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Sexual  disruption  in wild  ﬁsh  has  been  linked  to  the  contamination  of  river  systems  with  steroid  oestro-
gens,  including  the pharmaceutical  17-ethinylestradiol,  originating  from  domestic  wastewaters.  As
analytical  chemistry  has advanced,  more  compounds  derived  from  the  human  use  of pharmaceuticals
have  been  identiﬁed  in the  environment  and  questions  have  arisen  as to whether  these  additional  phar-
maceuticals  may  also  impact  sexual  disruption  in ﬁsh.  Indeed,  pharmaceutical  anti-androgens  have  been
shown  to induce  such  effects  under  laboratory  conditions.  These  are  of  particular  interest  since  anti-
androgenic  biological  activity  has  been  identiﬁed  in the  aquatic  environment  and  is  potentially  implicated
in  sexual  disruption  alone  and  in  combination  with steroid  oestrogens.  Consequently,  predictive  mod-
elling  was  employed  to determine  the  concentrations  of two  anti-androgenic  human  pharmaceuticals,
bicalutamide  and  cyproterone  acetate,  in UK  sewage  efﬂuents  and  river catchments  and  their  combined
impacts  on sexual  disruption  were  then  assessed  in  two ﬁsh  models.  Crucially,  ﬁsh  were  also  exposed  to
the anti-androgens  in  combination  with  steroid  oestrogens  to determine  whether  they  had  any  additional
impact  on  oestrogen  induced  feminisation.  Modelling  predicted  that  the  anti-androgenic  pharmaceu-
ticals  were  likely  to be  widespread  in UK  river  catchments.  However,  their  concentrations  were  not
sufﬁcient  to induce  signiﬁcant  responses  in plasma  vitellogenin  concentrations,  secondary  sexual  charac-
teristics or  gross  indices  in male  fathead  minnow  or  intersex  in  Japanese  medaka  alone  or in combination
with steroid  oestrogens.  However,  environmentally  relevant  mixtures  of oestrone,  17-oestradiol  and
17-ethinylestradiol  did  induce  vitellogenin  and  intersex,  supporting  their  role  in  sexual  disruption  in
wild  ﬁsh  populations.  Unexpectedly,  a male  dominated  sex  ratio  (100%  in controls)  was  induced  in  medaka
and the potential  cause  and  implications  are  brieﬂy  discussed,  highlighting  the potential  of  non-chemical
modes  of action  on  this  endpoint.
© 2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license. Introduction
Pharmaceuticals have emerged as contaminants of con-
ern in the aquatic environment, where they are present at
anogram–microgram per litre concentrations globally (Heberer,
002). They enter river systems primarily through sewage efﬂu-
nt, following patient excretion and incomplete removal during
ewage treatment. However, hospitals, manufacturers, landﬁlls
nd improper disposal by patients can also be prominent sources
∗ Corresponding author. Tel.: +44 1895 266267.
E-mail address: christopher.green@brunel.ac.uk (C. Green).
ttp://dx.doi.org/10.1016/j.aquatox.2014.12.022
166-445X/© 2015 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
(Bound and Voulvoulis, 2005; Larsson et al., 2007; Kümmerer,
2009). Some pharmaceuticals have the capacity to induce adverse
effects in non-target organisms through their speciﬁc interactions
with conserved drug targets (Gunnarsson et al., 2008; Rand-
Weaver et al., 2013). One of the most notorious examples is
17-ethinylestradiol (EE2), the active hormone in the contracep-
tive pill, which has been linked to feminisation of ﬁsh downstream
of sewage efﬂuent outfalls, alongside the other steroid oestro-
gens 17-oestradiol (E2) and oestrone (E1) (Desbrow et al., 1998;
Routledge et al., 1998; Jobling et al., 2006). Fish exposed to EE2 in
the low nanogram per litre range show dramatic decreases in repro-
ductive success, prompting concerns over the potential effects of
this chemical on ﬁsh populations (Kidd et al., 2007).
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Several studies have demonstrated that sexual disruption,
ncluding the induction of vitellogenin and intersex, occurs in ﬁsh
xposed to STW efﬂuents under laboratory conditions and in the
ild (Jobling et al., 1998; Bjerregaard et al., 2006; Jobling et al.,
006; Harris et al., 2011; Lange et al., 2011; Tetreault et al., 2011;
ahamonde et al., 2013). Whilst the steroid oestrogens are clearly
igniﬁcant contributors to intersex through disruption of normal
ndocrine function, the relative role of other pharmaceuticals that
o-occur with these compounds is unclear. Nonetheless, pharma-
euticals that can interact with hormone receptors or affect levels
f circulating hormones are in widespread use and many are pre-
cribed in greater amounts than the oestrogens (Runnalls et al.,
010). Of particular interest are anti-androgenic pharmaceuticals.
hese compounds are designed to disrupt the androgen signalling
athway through the competitive inhibition of androgen binding
o the androgen receptor (AR) by direct antagonism, or by reduc-
ng concentrations of circulating androgens (Kelce and Wilson,
997; Hotchkiss et al., 2008). Anti-androgenic activity has also
een detected in STW efﬂuents, river water and sediment glob-
lly (Conroy et al., 2007; Johnson et al., 2007b; Urbatzka et al.,
007; Weiss et al., 2009; Kumar et al., 2012; Kinani et al., 2010) and
here is some evidence of anti-androgenic pharmaceuticals poten-
ially occurring in low nanogram per litre concentrations (Besse
nd Garric, 2009; Al-Odaini et al., 2012; AZ.com, 2013).
Anti-androgens can cause demasculinisation of male ﬁsh
nder laboratory conditions, inducing similar phenotypes to those
bserved in the aquatic environment or through exposure to steroid
estrogens. These include intersex and vitellogenin induction,
ltered gene expression and reduced secondary sexual character-
stics, sperm counts and fecundity (Bayley et al., 2002; Kiparissis
t al., 2003; Jensen et al., 2004; Filby et al., 2007; Hatef et al., 2012).
urthermore, several studies have shown that the anti-androgenic
ctivity of some STW efﬂuents is equivalent to concentrations of
he anti-androgenic pharmaceutical, ﬂutamide, that are capable
f causing demasculinisation in ﬁsh during laboratory exposures
Jensen et al., 2004; Panter et al., 2004; Johnson et al., 2007b).
nti-androgenic impacts have been detected in wild stickleback
Gasterosteus aculeatus) downstream of a STW efﬂuent outfall in the
K (Katsiadaki et al., 2012) and anti-androgenic compounds have
een identiﬁed in the bile of ﬁsh exposed to STW efﬂuent (Hill et al.,
010; Rostkowski et al., 2011). However, the chemical contributors
o anti-androgenic activity in the environment are not well char-
cterised and pharmaceutical mixtures have not been investigated
rom this perspective.
This study aimed to determine whether the two of the most pre-
cribed anti-androgenic pharmaceuticals in the UK, bicalutamide
nd cyproterone acetate, could contribute to feminization of ﬁsh at
nvironmentally relevant concentrations. Both drugs are AR antag-
nists, although unlike bicalutamide, cyproterone acetate can also
nhibit androgen secretion by inhibiting gonadotrophin release
hrough its progestagenic activity (Mahler et al., 1998). Both can
ause demasculinising effects in male patients during treatment
hrough either intended or adverse effects, such as gynecomastia
nd reduced libido (Mahler et al., 1998; Bradford, 1999). In fact,
he use of cyproterone acetate to treat sexually deviant behaviour
n men  has been shown to be equivalent to surgical castration
Neumann and Kalmus, 1991). In ﬁsh, exposures to these com-
ounds caused similar effects to the steroid oestrogens, including
ntersex and impacts on reproduction (Kiparissis et al., 2003; Panter
t al., 2012). However, although they are likely environmental con-
aminants due to their prescription levels and patient excretion,
here are few available data on their environmental concentra-
ions and corresponding effects in ﬁsh. In addition, there has been
o assessment of the possibility of combined effects with steroid
estrogens, with which they are likely to co-occur in the aquatic
nvironment. This is warranted since outcomes of modelling of ﬁshogy 160 (2015) 117–127
ﬁeldwork studies indicated that anti-androgenic chemicals may
play a signiﬁcant role in sexual disruption alone and in combi-
nation with steroid oestrogens (Jobling et al., 2009). There is also
evidence from rodent studies that two  sets of chemicals with differ-
ent mechanisms of action can act additively on common endpoints
(Kortenkamp, 2008; Christiansen et al., 2009), although there may
in fact be some commonalities in the mode of action of oestrogens
and anti-androgens in ﬁsh at a molecular level (Filby et al., 2007).
To address these knowledge gaps, this study used predictive
modelling techniques to predict concentrations of bicalutamide
and cyproterone acetate in typical UK sewage efﬂuents. This was
later supplemented with modelling of concentrations in river
catchments in England and Wales to further investigate the wider
environmental relevance of the exposure concentrations. Such
techniques have already been used to predict concentrations of a
range of pharmaceuticals in STW efﬂuents and rivers (Schowanek
and Webb, 2002; Johnson et al., 2007a; Besse and Garric, 2009;
Johnson and Williams, 2004; Williams et al., 2009; Kugathas et al.,
2012) and comparisons of modelled and measured steroid oestro-
gens have been shown to compare well in two UK river catchments
(Williams et al., 2012). The modelled concentrations of bicalu-
tamide and cyproterone acetate from STW efﬂuents were employed
in two experiments using two appropriate ﬁsh models. These aimed
to determine whether the anti-androgenic pharmaceuticals could
induce effects associated with feminisation in ﬁsh, alone or in
combination with environmentally relevant mixtures of steroid
oestrogens.
2. Materials and methods
2.1. Prediction of sewage treatment works efﬂuent
concentrations of pharmaceutical anti-androgens
The NHS prescriptions cost analysis for England and Wales was
used to determine the annual consumption of bicalutamide and
cyproterone acetate in 2009 (based on Runnalls et al., 2010). The
daily per-capita consumption was  then calculated based on the
mid-2009 population (estimated as 54,809,100). Excretion rates of
55% for bicalutamide (Goa and Spencer, 1998) and 80.75%, cypro-
terone acetate (Speck et al., 1976; Humpel et al., 1977; Frith and
Phillipou, 1985), were incorporated to determine the microgram
per day of each drug excreted per capita as the parent compound
in faeces and urine. Efﬂuent concentrations (microgram per litre)
were calculated for four UK STWs in the Severn Trent catchment
based on the linear emission model:
Cefﬂuent =
pc × pop
QSTW
× (1 − R)
where the per capita excreted (pc) was multiplied by the popu-
lation served by the STW (pop) and divided by the ﬂow (L/day)
(Q) through the STW (Table S2). Since removal is expected to be
low for bicalutamide (Brixham Environmental Laboratory, 1998;
AZ.com, 2013) and no data were available for cyproterone acetate, a
removal percentage (R) was not incorporated. This provided a worst
case scenario where the total anti-androgenic pharmaceutical load
arriving at a STW was available to enter the aquatic environment.
These data are displayed in Tables S1 and S2.
2.2. Experimental test chemicals
Bicalutamide ≥98% (CAS No. 90357-06-5), cyproterone acetate
≥98% (CAS No. 427-51-0), oestrone (E1) ≥99% (CAS No. 53-
16-7), 17-oestradiol (E2) ≥99% (CAS No. 50-28-2) and 17-
ethinylestradiol (EE2) ≥98% (CAS No. 57-63-6) were purchased
from Sigma–Aldrich, Gillingham (UK). Concentrated stock solutions
were prepared with N,N-dimethylformamide (DMF) ≥99.8% (CAS
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o. 68-12-2) purchased from Fisher Scientiﬁc, UK for tank dosing
nd Absolute Ethanol 100 AR (CAS No. AR 64-17-5) purchased from
ayman Speciality Products, UK for Petri dish dosing in experiment
wo.
.3. Experiment one: vitellogenin induction and secondary sexual
haracteristics
.3.1. Experimental design, chemical concentrations and test
pecies
Experiment one was  carried out using the experimental sys-
em described by (Brian et al., 2005). Pre-spawning, male fathead
innow of approximately seven months of age were exposed to
eﬁned mixtures of steroid oestrogens and anti-androgenic phar-
aceuticals for 14 days. Fathead minnow were an appropriate
xperimental model for this experiment since males have a set of
ell-deﬁned androgen dependent secondary sexual characteristics
Ankley et al., 2004; Ankley et al., 2010). They are also large enough
n size to allow for the collection of sufﬁcient blood for vitellogenin
nalysis (Ankley and Johnson, 2004).
Six treatment groups were employed, including aquarium
ater and solvent controls, a steroid oestrogen treatment (E1,
2 and EE2), an anti-androgenic pharmaceutical treatment (bica-
utamide and cyproterone acetate) and a combined mixture
reatment containing both anti-androgenic pharmaceuticals and
teroid oestrogens. Concentrations of the anti-androgenic pharma-
euticals were based on the maximum concentrations predicted
or untreated efﬂuent (115 ng/L bicalutamide and 74 ng/L cypro-
erone acetate) using the equation described in Section 2.1. Since
he steroid oestrogens occur together in the environment, ﬁsh
ere exposed to an environmentally relevant mixture of 9.6 ng/L
1, 2.1 ng/L E2 and 0.3 ng/L EE2. These were within the range of
estrogen concentrations observed in a survey of UK efﬂuents and
heir proportions were based on the ratio of their highest detected
oncentrations (Johnson et al., 2007b). These concentrations had
 combined E2 equivalent (EEQ) of 8.3 ng/L, based on PNECs for
eproductive endpoints (as described in Young et al., 2004) and
ere expected to induce an intermediate response in vitellogenin
nduction based on their estimated EC50’s for this endpoint (Panter
t al., 1998; Brian et al., 2005). A positive control of 10 ng/L EE2 was
lso included. All treatments were run in duplicate with eight ﬁsh
er tank.
Chemical stocks were prepared at 50,000× the required expo-
ure concentration in 1 L DMF  and were pumped by peristaltic
ump through medical grade silicone tubing (Watson Marlow, UK)
o mixing vessels at a rate of 0.01 mL/min. This was mixed with
echlorinated and ﬁltered tap water from a header tank ﬂowing at
0 L/h via medical grade silicone tubing (VWR, UK), to produce the
esired concentrations in the exposure aquaria without exceed-
ng the maximum recommended concentration of 20 L/L of DMF
Hutchinson et al., 2006). Each tank had its own  mixing vessel,
lthough single stock bottles fed both replicates and the negative
ontrol ran directly off the header tank. Physical and physico-
hemical conditions were maintained at 25 ± 1 ◦C with dissolved
xygen exceeding 70% of air saturation and a photoperiod of 16:8 h
ight:dark with a 20 min  simulated dusk/dawn period of low light.
he ﬁsh were fed twice daily with ﬂaked food (Tetramin Flake,
M Fish Food, UK) and once daily with frozen adult brine shrimp
Tropical Marine Centre, Gamma  irradiated).
.3.2. Fish sampling and vitellogenin analysis
After 14 days of chemical exposure, ﬁsh were sacriﬁced by aethal dose of MS222 (500 mg/L), buffered to pH 7.4, in accordance
ith UK Home Ofﬁce Regulations. Blood was collected by caudal ﬁn
mputation with heparinised microhematocrit tubes and samples
ere centrifuged at 7000 × g for 5 min  at 4 ◦C to collect plasma,ogy 160 (2015) 117–127 119
which were stored at −80 ◦C. Fork length and wet weight were
recorded and the livers and gonads were excised and weighed for
hepatosomatic index (HSI) and gonadosomatic index (GSI). Sec-
ondary sexual characteristics, including the fatpad weight and the
tubercle number, were also recorded. Tubercle prominence was
then graded (scored 0–5) based on their level of development
(based on Smith, 1978). Plasma samples from individual ﬁsh were
then analysed by enzyme linked immunosorbent assay (ELISA) spe-
ciﬁc to fathead minnow (Biosense Laboratories AS, Norway).
2.4. Experiment two: intersex induction in Japanese medaka
(Oryzias latipes)
2.4.1. Experimental design, chemical concentrations and test
species
Japanese medaka were exposed from an embryo to early adult
stage over 98 days. This species can reach sexual maturity within
100 days, are sexually dimorphic and have well documented pro-
cess of gonad development (Ankley and Johnson, 2004). As in
experiment one, ﬁsh were treated with the anti-androgenic phar-
maceuticals, the steroid oestrogens and a combination of the two
sets of compounds. However, this treatment regime was  tested
at two different concentrations termed “high” and “low.” Con-
centrations of anti-androgenic pharmaceuticals were based on
those predicted from the UK sewage efﬂuents based on the equa-
tion described in Section 2.1. In addition, the concentrations of
steroid oestrogens predicted to occur at these STWs were also
employed, based on the same ﬂow regimens and populations
served (from Green et al., 2013). For the high concentrations, the
treatment concentrations originated from UK1: 115 ng/L bical-
tuamide, 74 ng/L cyproterone acetate, 29 ng/L E1, 4 ng/L E2 and
0.4 ng/L EE2 (17.7 ng/L EEQ). The low concentrations were based
on the lowest efﬂuent concentrations predicted for UK3: 53 ng/L
bicalutamide, 34 ng/L cyproterone acetate, 13 ng/L E1, 2 ng/L E2
and 0.2 ng/L EE2 (equivalent to 8.3 ng/L EEQ). The steroid oestro-
gen concentrations were both expected to induce an intermediate
incidence of intersex based on a concentration response of E2 in
medaka for the induction of intersex (Metcalfe et al., 2001). A pos-
itive control was  dosed at 50 ng/L E2, a concentration expected to
completely reverse the sex of males (Kinoshita et al., 2009), and an
aquarium water and solvent control were also employed to give a
total of nine treatments.
Each treatment was  replicated in duplicate with 25 ﬁsh per
tank (50 per treatment). Embryos were collected and exposure
was initiated at less than six hours post fertilisation. The embryos
were maintained under static renewal in covered glass Petri dishes
with 15 mL  of Modiﬁed FETAX (Frog Embryo Teratogenesis Assay-
Xenopus) Solution (MFS) (from Woods and Kumar, 2011) in an
incubator at 25 ± 1 ◦C with 16:8 h light:dark ratio. Over the ﬁrst
three days, unfertilised or dead embryos were replaced with new
fertilised embryos. Each Petri dish was  spiked with 10 L of a con-
centrated stock solution in absolute ethanol, which was allowed to
evaporate before 15 mL of MFS  was  added. Nonetheless, the solvent
control was  still spiked with ethanol only. Embryos were trans-
ferred, by pipette, to new Petri dishes with new stocks daily to
provide 24 h renewal of the exposure mixtures. As the embryos
hatched, larvae were transferred to 30 L exposure aquaria run with
the same ﬂow regimens as experiment one and were maintained in
mesh baskets for up to 14 days before being released into the aquar-
ium itself. Temperature was maintained at 26 ± 1 ◦C throughout the
majority of the study, although greater ﬂuctuations were observed
in some tanks on occasion. A photoperiod of 16:8 h light:dark with
a 20 min  simulated dusk/dawn period of low light was applied. Fish
were fed twice daily to excess with pellet food. This was supple-
mented with larval artemia and, eventually, frozen brine shrimp.
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issolved oxygen and various water parameters were monitored
hroughout the experiment.
.4.2. Fish sampling and histological analysis
After 98 days exposure, medaka were sacriﬁced by a lethal dose
f neutral buffered MS222 (500 mg/L). However, ﬁsh in the positive
ontrol treatment were sampled earlier at 90 days due to mortal-
ty during the exposure. The heads and tails were removed and the
ody was ﬁxed in bouins and stored in 70% IMS. The body cavity
as then opened from the side to reveal the gonad before being
xed in wax and serial sectioned longitudinally, with 5 m sam-
les taken every 150 m across the gonad. For smaller ﬁsh, the
ntire body was serial sectioned and for females with large ovaries,
he gonad was excised and split longitudinally into sections before
eing set in wax and serial sectioned in the same fashion as the
ales. Intersex incidence was quantiﬁed through light microscopy
y the presence or absence of oocytes and ovarian cavities and
everity was scored for each gonad section based on an intersex
ndex score of 0–6, shown in Table S3 (from Jobling et al., 2006), for
he number of oocytes. All slides were blinded prior to microscopic
nalysis.
.5. Chemical analysis
Concentrations of the exposure chemicals were analysed by
iquid chromatography tandem mass-spectrometry (LC–MS/MS).
he method for analysing steroid oestrogens was taken from the
tanding Committee of Analysts book on the detection of steroid
estrogens in water samples by mass spectrometry (Environment
gency, 2008). Methods were developed for detecting cyproterone
cetate and bicalutamide and are detailed in the Supporting Infor-
ation. Brieﬂy, in experiment one, 500 mL  samples from treatment
anks were collected on days 1 and 14. In experiment two, 100 mL
as collected on days 20, 34, 62 and 90 for solid phase extrac-
ion using C18 cartridges (Sep-Pak C18, Waters, UK). Extracts
nderwent HPLC (Aglient 1100 series) with a C18 column (Aglient
ORBAX Eclipse XDB-C18, 150 mm × 4.6 × 5 m.  Part No. 993967-
02). Detection and quantiﬁcation was carried out using an Applied
iosystems API5000 triple quadrupole mass spectrometer using
egative ion electrospray in multiple reaction monitoring mode for
icalutamide and the steroid oestrogens. Positive ion electrospray
as employed for cyproterone acetate. The concentrations were
hen calculated from calibration curves using deuterium labelled
nternal standard quantitation in Analyst 1.5.1 software (Thermo-
lectron Corporation) with d7-propanolol and d10-carbamazapine
or bicalutamide and cyproterone acetate, respectively. Limits
f detection (LOD) were determined as 5 ng/L bicalutamide and
0 ng/L cyproterone acetate. The LOD for the steroid oestrogens in
xperiment one was determined as 0.1 ng/L, compared with 1 ng/L
n experiment two. Analysis of samples yielded variable recovery,
hich in the case of cyproterone acetate could not be recovery
orrected using d10-carbamazapine. Consequently, the concentra-
ion of cyproterone acetate could not be accurately quantiﬁed in
amples and had to be predicted from the bicalutamide data using
ose ratio information. Concentrations of EE2 in samples could not
e reported directly due their low concentration in samples and
ere estimated from analysed E2 concentrations using dose ratio
nformation.
.6. Statistical analysis
In experiment one, parametric data underwent one way analysis
f variance (ANOVA) followed by post hoc all pairwise multi-
le comparison procedures (Holm–Sidak method). Non-parametric
ata was assessed by Kruskal–Wallis one way ANOVA on ranks
ollowed by post hoc all pairwise multiple comparison proceduresogy 160 (2015) 117–127
(Dunn’s method). Vitellogenin data were log transformed prior to
assessment and statistical signiﬁcance was accepted at P ≤ 0.05
for all tested endpoints. Treatment groups were all compared
with the solvent control. In experiment two, binary responses
(intersex incidence) were analysed using generalized linear mod-
elling approaches, assuming that the numbers of intersex ﬁsh
were binomial-distributed. Mean effects were estimated by Maxi-
mum likelihood, and treatment-related differences to the controls
were analysed by Williams contrast test (Hothorn, 2004). Ordinal
responses (intersex severity) were assumed to follow a common
slopes model with a cumulative logit link function, and correla-
tions from repeated measurements were estimated according to
the principles of generalized estimating equations (Agresti, 1984).
Odds ratio estimates were used to express relative differences
between treatment means. For the log odds scale, the cumula-
tive logit model is sometimes referred to as the proportional odds
model. Analysis of vitellogenin, secondary sexual characteristics
and gross indices was performed in SigmaStat 3.5 (Systat Software,
Chicago IL), whilst intersex analysis was  performed in SAS 9.3 (SAS
Institute, Cary NC).
2.7. Environmental relevance
In order to put the exposure concentrations into context and
to produce a more extensive picture of anti-androgenic pharma-
ceuticals in UK rivers, predictive modelling techniques were used
to estimate their concentrations in river catchments in the Eng-
land and Wales. Fourteen major river catchments accounting for
approximately 54% of land area and 69% of the population served
by STWs were assessed (Figure S3 A&B). The modelling exercise
used the Low Flows 2000 (LF2000) WQX  (Water Quality eXtension)
hydrological modelling platform, which provided a map  of the UK’s
interconnected river reaches with their variable ﬂows and artiﬁ-
cial inﬂuences incorporated (Williams et al., 2009). In this process,
STW’s were considered to be the only chemical input based on the
per capita excretion and once again a removal percentage was not
incorporated. There are no data available on the in-stream degra-
dation of the pharmaceutical anti-androgens, and so the model
produced a worst case scenario for their environmental concentra-
tions, only taking into account the effects of dilution of the efﬂuent
in downstream river stretches.
3. Results
3.1. Predicted environmental concentrations of anti-androgenic
pharmaceuticals
NHS prescriptions of bicalutamide and cyproterone acetate in
2009 were determined as 636 kg and 278 kg, respectively, which
produced per capita excretion rates of 17 and 11 g/day. When
these data were input to the linear emission model (Section 2.1),
concentrations of 53–115 ng/L for bicalutamide and 34–74 ng/L for
cyproterone acetate were predicted to occur in untreated efﬂuent
at the four UK STWs. The highest and lowest predicted concentra-
tions from this analysis were used as exposure concentrations for
experiments one and two. Subsequent hydrological modelling with
LF2000-WQX predicted that the presence of anti-androgenic phar-
maceuticals was widespread across river catchments in England
and Wales, downstream of STW discharges. The concentrations
on a majority of river stretches were below 10 ng/L, although
they were much higher on some stretches from both urban and
rural areas. Indeed, median concentrations of 9 (0.0002–157) ng/L
bicalutamide and 5 (0.0001–86) ng/L of cyproterone acetate were
predicted (Figure S3 A&B).
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Table 1
Chemical analysis of exposure tanks from experiments one and two  versus the nominal. In experiment one, samples analysed at the start and end of the exposure are indicated. In experiment two, the mean measured concentrations
(±  standard error) are displayed from analysis of up to four samples from throughout the study. Cyproterone acetate was predicted based on bicalutamide and, in experiment two, EE2 was predicted based on E2.
Experiment one Replicate Bicalutamide (ng/L) Cyproterone acetate (ng/L) E1 (ng/L) E2 (ng/L) EE2 (ng/L) EEQ (ng/L)
Treatment
Nominal Measured Nominal Predicted Nominal Measured Nominal Measured Nominal Measured Nominal Predicted
Anti-androgens A 115 94 (±27) 74.0 60 (±17) 0 <LOD 0 <LOD 0 <LOD 0 <LOD
B  115 121 (±64) 74.0 78 (±41) 0 <LOD 0 <LOD 0 <LOD 0 <LOD
Steroid  oestrogens A 0 <LOD 0 <LOD 9.6 10.3 (±1.1) 2.1 2.0 (±1.0) 0.3 0.3 (±0.1) 8.3 8.2 (±2.4)
B  0 <LOD 0 <LOD 9.6 8.7 (±1.9) 2.1 1.7 (±0.6) 0.3 0.2 (±0.1) 8.3 6.9 (±1.9)
Mixture A  115 94 (±29) 74.0 60 (±19) 9.6 10.6 (±3.1) 2.1 2.0 (±0.2) 0.3 0.3 (±0.1) 8.3 8.4 (±1.8)
B  115 90 (±17) 74.0 58 (±11) 9.6 7.0 (±4.4) 2.1 1.3 (±0.9) 0.3 0.2 (±0.1) 8.3 5.3 (±3.3)
Positive Control A 0 <LOD 0 <LOD 0 <LOD 0 <LOD 10.0 9.7 (±2.8) 100.0 97 (±28)
B  0 <LOD 0 <LOD 0 <LOD 0 <LOD 10.0 9.0 (±2.7) 100.0 90 (±27)
Experiment two  Replicate Bicalutamide (ng/L) Cyproterone acetate (ng/L) E1 (ng/L) E2 (ng/L) EE2 (ng/L) EEQ (ng/L)
Treatment
Nominal Measured Nominal Predicted Nominal Measured Nominal Measured Nominal Predicted Nominal Predicted
Low anti-androgens A 53 99 (±18) 32 57 (±8) 0 <LOD 0 <LOD 0 <LOD 0 <LOD
B  53 71 (±7) 32 43 (±4) 0 <LOD 0 <LOD 0 <LOD 0 <LOD
Low  oestrogens A 0 <LOD 0 <LOD 13 24 (±2) 2 3.2 (±0.4) 0.2 0.3 (±0.04) 8 14 (±1)
B  0 <LOD 0 <LOD 13 27 (±4) 2 3.4 (±0.4) 0.2 0.3 (±0.04) 8 16 (±2)
Low  mixture A 53 107 (±6) 32 64 (±4) 13 33 (±6) 2 3.9 (±0.8) 0.2 0.4 (±0.08) 8 20 (±4)
B  53 85 (±16) 32 52 (±10) 13 34 (±5) 2 3.7 (±0.8) 0.2 0.4 (±0.08) 8 20 (±4)
High  anti-androgens A 115 133 (±14) 74 85 (±9) 0 <LOD 0 <LOD 0 <LOD 0 <LOD
B  115 152 (±11) 74 98 (±7) 0 <LOD 0 <LOD 0 <LOD 0 <LOD
High  oestrogens A 0 <LOD 0 <LOD 29 63 (±2) 4 8.3 (±0.7) 0.4 0.8 (±0.07) 18 37 (±2)
B  0 <LOD 0 <LOD 29 66 (±7) 4 6.8 (±0.4) 0.4 0.7 (±0.04) 18 36 (±3)
High  mixture A 115 99 (±30) 74 64 (±19) 29 64 (±10) 4 8.7 (±1.9) 0.4 0.9 (±0.19) 18 39 (±2)
B  115 134 (±5) 74 86 (±3) 0 61 (±7) 4 9.5 (±2.2) 0.4 1.0 (±0.22) 18 39 (±3)
Positive  control A 0 <LOD 0 <LOD 0 <LOD 50 76 (±4) 0 <LOD 50 77 (±5)
B  0 <LOD 0 <LOD 0 <LOD 50 80 (±10) 0 <LOD 50 81 (±11)
1 oxicology 160 (2015) 117–127
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Fig. 1. Log. vitellogenin concentrations in the blood plasma of fathead minnow from
each treatment group. Vitellogenin was not quantiﬁed in some cases when values
were outside of the working range of the assay (N number of samples is indicated
out  of 16 ﬁsh). Boxes represent the median with 25th and 75th percentiles and error
bars  extending to the 95th percentile with outliers shown as dots. The labels A and22 C. Green et al. / Aquatic T
.2. Chemical analysis
The results of chemical analysis are displayed below in Table 1.
oncentrations of bicalutamide were successfully determined.
owever, whilst cyproterone acetate was successfully detected
n the anti-androgen and mixture treatment tanks it could not
e accurately quantiﬁed due to the unreliable quantiﬁcation of
he internal standard. Concentrations of cyproterone acetate were
nstead predicted based on its expected ratio to bicalutamide, with
hich it had been combined in the stock solutions. In experiment
ne, all compounds were close to nominal with good agreement
etween replicates as well as between the single activity and com-
ined mixture treatments. In experiment two, the concentrations
ended to be around 200% of nominal due to issues in maintain-
ng header tank pressure, which caused sporadic reductions the
ow and therefore the dilution of the chemicals. Nonetheless, envi-
onmentally relevant concentrations were maintained throughout
he experiment based on predictive modelling for anti-androgenic
harmaceuticals and reported oestrogen concentrations from UK
ivers and efﬂuents (Johnson et al., 2007b; Williams et al., 2009).
E2 was below the 1 ng/L LOD of the method and was  instead pre-
icted based on the measured concentration of E2. Good agreement
as achieved between replicate tanks and between single activity
nd mixture treatment tanks. Concentrations of steroid oestrogens
n the high and low mixtures differed, whilst the anti-androgens
ere more similar.
.3. Experiment one: vitellogenin induction, secondary sexual
haracteristics and gross indices
Vitellogenin levels in the blood plasma of juvenile male fathead
innows varied signiﬁcantly between treatments (Fig. 1). Treat-
ent with the anti-androgenic pharmaceutical alone caused a two
old increase in the median vitellogenin concentration in compar-
son to the solvent control, but this difference was  not statistically
igniﬁcant at the 95% level. As expected, the steroid oestrogen
ixture signiﬁcantly induced vitellogenin. The combined mixture
f oestrogens and anti-androgens also signiﬁcantly induced vitel-
ogenin compared with the solvent control and again, although the
edian was two-fold higher than the oestrogens alone, it was still
ot statistically signiﬁcant. GSI signiﬁcantly varied between treat-
ent groups but there were no statistically signiﬁcant differences
etween the treatment groups and the solvent control (Figure S5).
n comparison, HSI did not signiﬁcantly vary. For the secondary
exual characteristics, only tubercle number and prominence were
igniﬁcantly reduced by the EE2 positive control, whereas the fat-
ad was unaffected. Apart from this there was no statistically
igniﬁcant impact of the oestrogen, anti-androgen and combination
reatment on these endpoints (Figure S6).
Fig. 2. The proportions of intersex, male, female and unknown JapaneseB  denote a statistically signiﬁcant difference between groups at p ≤ 0.05.
3.4. Experiment two: intersex induction and severity
Due to the long term nature of this study, some mortality was
unavoidable. This occurred in all treatment groups during the
experiment. On average, survival was  over 80%. However, lower
survival was  observed in one water control tank (56%) and a solvent
control tank (72%). Survival was also lower in the two  positive con-
trol tanks (60% and 68%), which were sampled early after 91 days as
a result. The exact cause for mortality was unknown, although in the
control tank temperature ﬂuctuations could be implicated. Indeed,
this tank experienced a greater temperature range (5.7 ◦C) than the
other tanks in this experiment. In the case of the positive con-
trols, previous studies have observed mortality in ﬁsh associated
with very high vitellogenin induction, which would be expected
 medaka within the treated populations based on gonad histology.
C. Green et al. / Aquatic Toxicology 160 (2015) 117–127 123
Fig. 3. Images show a normal male gonad from the solvent control (A), sporadic oocytes in the testes (shown with arrows) typical of the low oestrogen and low mixture
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areatment (B), increased abundance and clustering of oocytes in the testes typical 
he  testes of some high oestrogen and high mixture treated ﬁsh (D). The graph belo
oxes  represent the odds ratio value and extend to the 95% conﬁdence limits where
n the sex reversed males observed in this treatment (Herman and
incaid, 1988).
At the time of sampling, whilst all Japanese medaka in the
ositive control population appeared phenotypically female char-
cteristics, the water and solvent controls appeared exclusively
ale and a male majority was observed in all other treatments
ased on their external appearance. This unexpected result was
onﬁrmed with gonad histology.
Intersex was based only on the presence of oocytes in testicu-
ar tissue since ovarian cavities could not be properly quantiﬁed in
he longitudinal sections. Treatment of Japanese medaka with the
ow and high steroid oestrogen concentrations induced intersex
n 22% and 70% (Fig. 2) of the respective treatment populations.
owever, only the high oestrogen treatment induced what was
onsidered a signiﬁcant induction of intersex in comparison to
he solvent control, where intersex was identiﬁed in 6% of the
reatment population. A small proportion of ﬁsh in the low anti-
ndrogen treatment were also found to be intersex (6%), which did
ot signiﬁcantly differ from the solvent control and no intersex ﬁsh
ere found in the high anti-androgen treatment. Interestingly, in
oth the low and high mixture treatments, the number of inter-
ex individuals was 9% and 10% higher, respectively, than their
orresponding oestrogen treatments alone. However, whilst inter-
ex incidence in these treatments was signiﬁcantly higher than
he solvent control, there was no signiﬁcant difference in inter-
ex induction between the mixture treatments and their respective
estrogen treatments.
Fig. 3 summarises the outcomes from the data analysis when
onsidering the severity of intersex. Intersex ﬁsh in the low anti-
ndrogen treatment was found to be at a low severity (index 1),
hich did not signiﬁcantly differ from that occurring in the solvent
ontrol. In comparison, severity in the low oestrogen and the low
ixture treatments was statistically similar with an index around
–2. Intersex index in these treatments was signiﬁcantly higher
han the solvent control. No intersex ﬁsh were identiﬁed in the high
nti-androgen treatment and severity of intersex in the high oestro- high oestrogen and high mixture (C) and the extensive ﬁbrosis which occurred in
ws statistical comparisons of the intersex severity between treatment groups. The
niﬁcant difference is judged when the boxes exceed the value of 1 (indicated by *).
gen and high mixture treatments was  signiﬁcantly higher than in
the lower treatments. Histological similarities were observed in
these two  treatment groups with ﬁsh identiﬁed across all bands of
severity, with a tendency towards higher severity (4–6). In addition,
ﬁsh in these treatments had increased levels of lobular disorgani-
sation in both intersex and non-intersex males. Fibrotic tissue was
also identiﬁed and, in some cases, it was severe enough to make up
a majority of the gonad tissue. Furthermore, intersex ﬁsh within
both treatment groups showed reductions in spermatozoa in the
sperm ducts in comparison to solvent control ﬁsh. In some ﬁsh,
particularly those with extensive ﬁbrosis, the ducts were empty
(Figure S7). As a result, intersex ﬁsh with testes made up primarily
of ﬁbrotic tissue were classiﬁed as index 6 in statistical analysis.
The few female ﬁsh which were identiﬁed in the treatment groups
were conﬁrmed as histologically female.
4. Discussion
This study aimed to determine the biological signiﬁcance of the
presence of anti-androgenic pharmaceuticals in the aquatic envi-
ronment by assessing their impacts on sexual disruption in ﬁsh,
alone and in combination with co-occurring steroid oestrogens. The
results indicated that environmentally relevant concentrations of
up to 157 ng/L bicalutamide and 86 ng/L cyproterone acetate were
not sufﬁcient to induce signiﬁcant effects in ﬁsh either alone or
in combination with the steroid oestrogens. However, this study
clearly demonstrated that environmentally relevant mixtures of
steroid oestrogens were capable of causing sexual disruption in
ﬁsh, in terms of both vitellogenin induction and intersex. However,
secondary sexual characteristics, GSI and HSI in fathead minnow
were unaffected, and previous studies suggest that higher concen-
trations are required to impact these endpoints (Miles-Richardson
et al., 1999; Filby et al., 2007; Salierno and Kane, 2009). Indeed,
in this study only 10 ng/L EE2 in the positive control signiﬁ-
cantly reduced tubercle number and prominence, although a longer
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xposure to this concentration may  have been required to affect
ross indices (Filby et al., 2007).
The induction of intersex by a mixture of steroid oestrogens
nvites the question of whether this was an effect of a single
hemical or a combination of all three steroid oestrogens. Addi-
ive effects of steroid oestrogens are well documented and have
een observed both in vitro and in vivo, on endpoints including
itellogenin production, fecundity and secondary sexual character-
stics in combination with other xenoestrogens (Thorpe et al., 2001;
ajapakse et al., 2002; Silva et al., 2002; Brian et al., 2005, 2007).
owever, additive effects have not been demonstrated for intersex,
lthough they are plausible. It should be noted that the concen-
rations of E2 and EE2 in the low oestrogen treatment were below
heir reported LOECs of 0.75 ng/L EE2 (Zhao et al., 2014) and 10 ng/L
2 for intersex induction (Metcalfe et al., 2001). In comparison,
1 was detected above its LOEC of 10 ng/L (Metcalfe et al., 2001).
owever, the 10 ng/L E1 exposure of Japanese medaka during early
ife only induced 5% intersex, whilst 100 ng/L induced 7% intersex
n the same study. In comparison, a much greater intersex inci-
ence of 24% of male ﬁsh was observed in experiment two in this
tudy. However, without detailed concentration response curves
rom single chemical exposures it is not possible to mathematically
rove additive effects for this endpoint in this study. Nonetheless,
t remains clear that environmentally relevant concentrations of
teroid oestrogens are major drivers of intersex induction.
In comparison, the environmentally relevant concentrations
f anti-androgenic pharmaceuticals had no signiﬁcant impact on
he measured endpoints alone, when dosed without the addi-
ion of steroid oestrogens. Previous studies have found that these
ndpoints can be affected by anti-androgenic pharmaceuticals in
ingle chemical exposure scenarios. However, the concentrations
equired to induce signiﬁcant effects were in the microgram per
itre range, 1000 times higher than the exposure concentrations
n this study. For example, bicalutamide reduced tubercle promi-
ence at 100 g/L (Panter et al., 2012), whilst cyproterone acetate
t concentrations up to 200 g/L failed to have any signiﬁcant
mpact on this endpoint (Ankley et al., 2010). Vitellogenin induc-
ion by anti-androgens has also been documented. One study
nduced around a six fold increase in male fathead minnow fol-
owing exposed to 500 g/L of the pure AR antagonist ﬂutamide
Jensen et al., 2004). In the current study, vitellogenin appeared
lightly elevated above the solvent control in the anti-androgen
reatment and in the mixture treatment in comparison to oestro-
ens alone, but this was not statistically signiﬁcantly higher. There
re no other studies of bicalutamide available for comparison
ith this endpoint. However, there is some evidence to suggest
hat it may  act at similar concentrations to ﬂutamide in rodent
tudies and it is therefore plausible that concentrations in the
icrogram per litre range may  be required to produce signiﬁ-
ant changes in vitellogenin in male ﬁsh (Chandolia et al., 1991;
aucher and Von Angerer, 1993). In contrast, cyproterone acetate
educed vitellogenin in female fathead minnow at 200 g/L, pos-
ibly due to a reduction in endogenous sex steroids caused by
ts anti-gonadotrophic effects in addition to its AR antagonism
Ankley et al., 2010). By acting through both mechanisms, cypro-
erone acetate caused more pronounced effects than ﬂutamide
n mammalian models and in human trials for prostate cancer
reatment at similar doses (Barradell and Faulds, 1994). Indeed, in
sh studies, ﬂutamide caused intersex in medaka above 200 g/L
Kang et al., 2006; León et al., 2007) in comparison to cyproterone
cetate at 1 and 10 g/L (Kiparissis et al., 2003). At the concentra-
ions employed in this study, cyproterone acetate has also been
hown to reduce both the testicular synthesis and plasma concen-
rations of testosterone and 11-ketotestosterone in mummichog
Sharpe et al., 2004). However, this was not measured in this
tudy.ogy 160 (2015) 117–127
An unexpected ﬁnding of experiment two  was the heavily male
biased sex ratio in the controls and all chemical treatments apart
from the positive control. Sex ratio can be altered by chemical expo-
sure (Örn et al., 2006) and it is used as an endpoint within the
OECD’s ﬁsh sexual development test (Test 234) (OECD, 2011). It has
gained interest for regulatory purposes as an endpoint for identify-
ing endocrine disruptors, since it can be considered to demonstrate
both an adverse effect and an endocrine mode of action, partic-
ularly when used in conjunction with other endpoints, such as
vitellogenin induction (Crane et al., 2010; Munn and Goumenou,
2013; Dang, 2014). However, sexual differentiation in ﬁsh can
also be driven by environmental factors, including temperature,
hypoxia and even changes in social hierarchy, depending on the
species (Devlin and Nagahama, 2002). In medaka, thermal manip-
ulation during the larval and embryo stage has been shown to
induce masculinisation of genotypic XX females with exposure
to increased temperature (Sato et al., 2005; Hattori et al., 2007;
Kitano et al., 2012). This is thought to occur through an increase
in cortisol in response to external temperature change, which was
shown to cause suppression of germ cell proliferation, follicle stim-
ulating hormone receptor expression and ovarian-type aromatase
(cyp19a1), as well as inhibition of oogenesis (Hayashi et al., 2010;
Kitano et al., 2012). However, the masculinisation effect induced
by high temperature or cortisol treatment was  shown to be pre-
vented by co-exposure with E2, (Kitano et al., 2012). This provides
a good explanation for male dominated sex ratios in this study,
which could have been caused by temperature changes during
media renewal in the embryonic phase, where MFS  water was
kept at room temperature and not under incubation. However, this
could not be proven. Since E2 can challenge the masculinisation
response to temperature changes (Kitano et al., 2012), statistical
analysis of intersex induction and severity was  rerun with female
histopathology considered as an experimental response, with an
intersex index of seven. However, the results were still no different
from the original analysis.
Phenotypic males produced by temperature induced sex rever-
sal have been found to have histologically normal, male testes and
were capable of successfully reproducing (Hattori et al., 2007). Con-
trol ﬁsh in this study were also found to have histologically normal
testes. This suggests that they still provide a sufﬁcient platform for
the induction of intersex by exogenous chemicals. Indeed, future
experiments could even use temperature in a more controlled fash-
ion to increase the n number of phenotypically male or female
ﬁsh for assessment of sex reversal or intersex induction. Nonethe-
less, the male dominated sex ratios highlight the importance of
maintaining experimental conditions during chemical exposure
studies and recognising the possibility of non-chemical effects on
this endpoint. It also supports the role of medaka in the ﬁsh sexual
development test, since it has a well-deﬁned genotypic sex deter-
mining gene (DMY) (Matsuda, 2005), which could be used to assess
non-chemical sex reversal in controls.
Whilst we found no evidence that the anti-androgenic phar-
maceuticals could enhance or diminish a response to oestrogen
exposure, there still remains a possibility that oestrogenic and anti-
androgenic contaminants could act on ﬁsh in combination in the
environment, as indicated by Jobling et al. (2009). Indeed, com-
pounds with similar mechanisms of action, such as AR antagonists
and steroidogenesis inhibitors, have been shown to act additively or
even synergistically in vivo on common endpoints in rodent models
(Christiansen et al., 2009; Hotchkiss et al., 2010). In ﬁsh, ﬂutamide
has also been shown to increase the expression of oestrogen recep-
tors  ˇ and  in fathead minnow (Filby et al., 2007) and oestrogen
receptor  ˛ in Murray rainbowﬁsh (Bhatia et al., 2014), suggest-
ing that there may  be some common modes of action between AR
antagonists and oestrogens. Crucially, preliminary data from one
study has reported an increase in the incidence of ovarian cavities
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n juvenile roach following exposure to a combination of anti-
ndrogens identiﬁed in STW efﬂuents (by Rostkowski et al., 2011)
nd steroid oestrogens (Lange et al., 2012). It may  be that the total
nti-androgenic activity present in the environment, represent-
ng a larger number of compounds, could cause sexual disruption
n ﬁsh in combination with oestrogens. However, so far attempts
o characterise anti-androgenic activity in environmental samples
as found that the identiﬁed anti-androgenic compounds cannot
xplain the total activity detected (Urbatzka et al., 2007; Kinani
t al., 2010). It may  be that a large number of compounds are
ontributing, of which the anti-androgenic pharmaceuticals are
 factor. Indeed, preliminary results from the Tox21 programme
ound that almost 10% of the 1,462 compounds tested were andro-
en receptor antagonists in vitro, which supports the possibility
f a large number of contributors to environmental activity (Tice
t al., 2013). Consequently, further study is warranted to identify
igniﬁcant environmental anti-androgens and to determine their
nvironmental impacts, particularly with respect to the possibility
f a multi-causal aetiology to sexual disruption observed in wild
sh.
. Conclusions
Hydrological modelling predicted that bicalutamide and cypro-
erone acetate are likely to be widespread contaminants in rivers
n England and Wales. In a majority of cases, their concentrations
re likely to occur below 10 ng/L, but at many “hot spots” concen-
rations are likely to be higher, in some cases exceeding 100 ng/L
or bicalutamide. However, exposures of ﬁsh to these high envi-
onmental concentrations suggested that they are not likely to be
 threat to ﬁsh reproductive health. Indeed, it is likely that concen-
rations one magnitude higher than those predicted to occur in the
nvironment are required to induce signiﬁcant responses associ-
ted with feminisation of wild ﬁsh. However, given the evidence
or additive effects of anti-androgenic chemicals in whole organ-
sms, these environmental contaminants should be considered as
art of the wider issue of anti-androgenic activity in the environ-
ent. Critically, this study demonstrates that a mixture of steroid
estrogens, at concentrations present in the aquatic environment,
an induce intersex at a rate comparable with that observed in
K and European rivers. Additional exposures to anti-androgenic
harmaceuticals known to co-occur with these oestrogens did not
xacerbate the incidence or severity of intersex. Taken together,
hese data support the role of steroid oestrogens as major contrib-
tors to intersex in wild ﬁsh.
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